The Clorox Company (NYSE:CLX) Shares Sold by BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp trimmed its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 12.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,719 shares of the company's stock after selling 3,050 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp's holdings in Clorox were worth $3,375,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Prospera Private Wealth LLC bought a new position in shares of Clorox during the third quarter valued at approximately $27,000. Innealta Capital LLC purchased a new position in shares of Clorox in the 2nd quarter valued at approximately $30,000. Trifecta Capital Advisors LLC raised its position in shares of Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock valued at $30,000 after purchasing an additional 130 shares during the last quarter. Family Firm Inc. purchased a new position in shares of Clorox in the 2nd quarter valued at approximately $31,000. Finally, Quarry LP raised its position in shares of Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company's stock valued at $31,000 after purchasing an additional 114 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CLX has been the subject of a number of recent research reports. DA Davidson raised their price target on shares of Clorox from $153.00 to $171.00 and gave the stock a "neutral" rating in a research report on Monday, November 4th. Citigroup lifted their price target on shares of Clorox from $165.00 to $170.00 and gave the company a "neutral" rating in a research note on Friday, September 6th. BNP Paribas raised shares of Clorox to a "strong sell" rating in a research note on Friday, September 6th. JPMorgan Chase & Co. lifted their price target on shares of Clorox from $148.00 to $174.00 and gave the company a "neutral" rating in a research note on Friday, October 11th. Finally, TD Cowen upgraded Clorox from a "sell" rating to a "hold" rating and raised their price objective for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Five equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, Clorox presently has an average rating of "Hold" and an average target price of $155.00.

Insider Transactions at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This represents a 11.40 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.57% of the company's stock.

Clorox Trading Up 0.2 %

CLX traded up $0.39 on Wednesday, hitting $167.52. The company had a trading volume of 837,488 shares, compared to its average volume of 1,234,656. The firm has a market cap of $20.74 billion, a P/E ratio of 58.37, a PEG ratio of 3.08 and a beta of 0.42. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.35. The company's fifty day moving average price is $163.27 and its 200 day moving average price is $150.02. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. Clorox's revenue was up 27.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.49 EPS. As a group, equities analysts expect that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 2.91%. Clorox's dividend payout ratio is presently 170.03%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.